Philippines vs Togo: Population requiring preventive chemotherapy for schistosomiasis
Philippines
3.21 million
in 2024
Togo
3.19 million
in 2024
Philippines rank
24th
Togo rank
25th
Population requiring preventive chemotherapy for schistosomiasis over time
- Philippines
- Togo
How they compare
Philippines currently reports 3.21 million against 3.19 million in Togo, a difference of 18,040.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Togo ahead.
Philippines ranks 24th and Togo ranks 25th of 52 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Philippines | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.79 million | 2.69 million | 901,590 | Togo |
| 2020s | 2.87 million | 3.39 million | 524,494 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Philippines or Togo?
- Philippines, at 3.21 million against 3.19 million in Togo as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Philippines and Togo?
- 18,040, with Philippines ahead.
- How many years of comparable data are there for Philippines and Togo?
- 15 years are reported by both, from 2010 to 2024.
- How do Philippines and Togo rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Philippines ranks 24th and Togo ranks 25th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.